Protara Therapeutics (TARA) Preferred Dividend Payments (2013 - 2017)

Protara Therapeutics (TARA) has 3 years of Preferred Dividend Payments data on file, last reported at $6.7 million in Q3 2017.

• On a quarterly basis, Preferred Dividend Payments changed N/A year-over-year to $6.7 million in Q3 2017; TTM through Sep 2017 was $16.5 million, a 41.6% increase from a year earlier, with the FY2014 full-year figure at $6.4 million, up 203.82% from the prior year.
• Preferred Dividend Payments for Q3 2017 stood at $6.7 million, down from $12.0 million in the prior quarter.
• Over the last five years, Preferred Dividend Payments for TARA reached as high as $12.0 million in Q4 2014 and fell as low as -$10.7 million in Q4 2013.
• Historically, Preferred Dividend Payments has averaged $1.5 million across 3 years, with a median of $1.5 million in 2013.
• On a YoY basis, Preferred Dividend Payments climbed as much as 212.54% in 2014 and fell as far as 247.86% in 2014.
• Year by year, Preferred Dividend Payments stood at -$10.7 million in 2013, then jumped by 212.54% to $12.0 million in 2014, then slumped by 43.96% to $6.7 million in 2017.
• Per Business Quant data, the three most recent Preferred Dividend Payments figures were $6.7 million in Q3 2017, $12.0 million in Q4 2014, and -$2.3 million in Q3 2014.